Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury

This publication has 35 references indexed in Scilit:

• Metallothionein: In Vitro Induction With Zinc and Streptozotocin in Pancreatic Islets of Mice
  Experimental and Clinical Endocrinology & Diabetes, 1995
• Therapeutic uses of recombinant complement protein inhibitors
  Springer Seminars in Immunopathology, 1994
• Mouse Crry/p65 is a regulator of the alternative pathway of complement activation
  European Journal of Immunology, 1993
• Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.
  The Journal of Experimental Medicine, 1992
• Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement
  Clinical Immunology and Immunopathology, 1991
• Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis
  Kidney International, 1989
• Immune complex induced glomerular lesions in C5 sufficient and deficient mice
  Kidney International, 1986
• Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.
  Journal of Clinical Investigation, 1986
• A new role for complement in experimental membranous nephropathy in rats.
  Journal of Clinical Investigation, 1980
• COMPLEMENT-FIXING ISLET-CELL ANTIBODIES IN TYPE-I DIABETES: POSSIBLE MONITORS OF ACTIVE BETA-CELL DAMAGE
  The Lancet, 1980